Startups
2022
YSOTOPE THERANOSTICS SLYSOTOPE designs new targeted radiotracers for monitoring CAR-T cells.
YSOTOPE uses specific ligands to design co-diagnostic radiotracers to monitor CAR-T cells inside the patient’s body.
YSOTOPE uses specific ligands to design co-diagnostic radiotracers to monitor CAR-T cells inside the patient’s body.
Address
Passeig de la Vall d'Hebron 129, 08035 Barcelona, Spain
Finance Data
| Date | Investors | Amount | Stage | |
| Mar 2023 | 1 € | Pre-Seed | ||
| Mar 2023 | 1 € | Seed |
Financial Overview
No revenue recorded yet
CERCA ownership
Barcelona, Spain
2002
Vall d’Hebron Institut de Recerca (VHIR)
Status & Deeptech areas
Company Status & Company Deeptech AreasCurrent company status
DeepTech Area
Spinoff information
Company Description
Ysotope's objective is to design, validate, and monetize new targeted radiopharmaceuticals for precision oncology.
Product description
CAR-T MONITORING RADIOTRACERS
PROBLEM: The loss of CAR-T in blood is a problem for oncologists making them more difficult to personalize the treatment.
SOLUTION: Molecular imaging is a non-invasive solution for providing information about CAR-T therapy to oncologists.
TECHNOLOGY: PET radiotracers are contrast agents that allow molecular imaging using a medical PET scanner.
PROBLEM: The loss of CAR-T in blood is a problem for oncologists making them more difficult to personalize the treatment.
SOLUTION: Molecular imaging is a non-invasive solution for providing information about CAR-T therapy to oncologists.
TECHNOLOGY: PET radiotracers are contrast agents that allow molecular imaging using a medical PET scanner.
Company Closed or Exit Year